Book contents
- Medication-Resistant Epilepsy
- Medication-Resistant Epilepsy
- Copyright page
- Dedication
- Contents
- Contributors
- Chapter 1 The Natural History of Epilepsy
- Chapter 2 Challenges in Identifying Medication-Resistant Epilepsy
- Chapter 3 International League Against Epilepsy’s Definition of Medication-Resistant Epilepsy
- Chapter 4 The Economic Impact of Medication-Resistant Epilepsy
- Chapter 5 Social Consequences of Medication-Resistant Epilepsy
- Chapter 6 Mortality and Morbidity of Medication-Resistant Epilepsy
- Chapter 7 Models for Medication-Resistant Epilepsy
- Chapter 8 Neurobiology of Medication-Resistant Epilepsy
- Chapter 9 Genetic Causes of Medication-Resistant Epilepsy
- Chapter 10 Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy
- Chapter 11 Hippocampal Sclerosis as a Cause of Medication-Resistant Epilepsy
- Chapter 12 Autoimmune Causes of Medication-Resistant Epilepsy
- Chapter 13 Medication-Resistant Epilepsy Syndromes in Children
- Chapter 14 Medication-Resistant Epilepsy in Adults
- Chapter 15 Approach to the Treatment of Medication-Resistant Epilepsy
- Chapter 16 Pharmacotherapy for Medication-Resistant Epilepsy
- Chapter 17 Reproductive Health for Women with Medication-Resistant Epilepsy
- Chapter 18 Resective Surgery for Medication-Resistant Epilepsy
- Chapter 19 Ablative Surgery for Medication-Resistant Epilepsy
- Chapter 20 Stimulation Treatment for Medication-Resistant Epilepsy
- Chapter 21 Diet Therapy for Medication-Resistant Epilepsy
- Chapter 22 Botanical Treatments for Medication-Resistant Epilepsy
- Chapter 23 Psychiatric Comorbidities in Medication-Resistant Epilepsy
- Index
- References
Chapter 18 - Resective Surgery for Medication-Resistant Epilepsy
Published online by Cambridge University Press: 20 August 2020
- Medication-Resistant Epilepsy
- Medication-Resistant Epilepsy
- Copyright page
- Dedication
- Contents
- Contributors
- Chapter 1 The Natural History of Epilepsy
- Chapter 2 Challenges in Identifying Medication-Resistant Epilepsy
- Chapter 3 International League Against Epilepsy’s Definition of Medication-Resistant Epilepsy
- Chapter 4 The Economic Impact of Medication-Resistant Epilepsy
- Chapter 5 Social Consequences of Medication-Resistant Epilepsy
- Chapter 6 Mortality and Morbidity of Medication-Resistant Epilepsy
- Chapter 7 Models for Medication-Resistant Epilepsy
- Chapter 8 Neurobiology of Medication-Resistant Epilepsy
- Chapter 9 Genetic Causes of Medication-Resistant Epilepsy
- Chapter 10 Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy
- Chapter 11 Hippocampal Sclerosis as a Cause of Medication-Resistant Epilepsy
- Chapter 12 Autoimmune Causes of Medication-Resistant Epilepsy
- Chapter 13 Medication-Resistant Epilepsy Syndromes in Children
- Chapter 14 Medication-Resistant Epilepsy in Adults
- Chapter 15 Approach to the Treatment of Medication-Resistant Epilepsy
- Chapter 16 Pharmacotherapy for Medication-Resistant Epilepsy
- Chapter 17 Reproductive Health for Women with Medication-Resistant Epilepsy
- Chapter 18 Resective Surgery for Medication-Resistant Epilepsy
- Chapter 19 Ablative Surgery for Medication-Resistant Epilepsy
- Chapter 20 Stimulation Treatment for Medication-Resistant Epilepsy
- Chapter 21 Diet Therapy for Medication-Resistant Epilepsy
- Chapter 22 Botanical Treatments for Medication-Resistant Epilepsy
- Chapter 23 Psychiatric Comorbidities in Medication-Resistant Epilepsy
- Index
- References
Summary
Resective epilepsy surgery is to date the most effective treatment for focal medication-resistant epilepsy. In multiple retrospective studies the median percentage for remaining seizure-free is approximately 60–65%, depending on the epilepsy syndrome [1]. Surgery for epilepsy was pioneered by Penfield in the first part of the twentieth century and has been refined since, with advanced imaging and neurophysiologic recordings [2]. Despite the obvious success, surgery remains underutilized [1,3]. If seizures are focal in onset and medication resistant, which is defined by the ILAE as having failed two anti-epileptic medications at standard doses, surgical evaluation at a specialized centre is indicated [4].
- Type
- Chapter
- Information
- Medication-Resistant EpilepsyDiagnosis and Treatment, pp. 198 - 209Publisher: Cambridge University PressPrint publication year: 2020